5-lipoxygenase-activating protein (FLAP) inhibitors

Details 5-lipoxygenase-activating protein (FLAP) inhibitors 5-lipoxygenase-activating protein (FLAP) inhibitors

2008-07-29

2008-07-29

Seaman, Margaret D. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07405302

ABSTRACT:
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

REFERENCES:
patent: 5081138 (1992-01-01), Gillard et al.
patent: 2004/0198800 (2004-10-01), Allan et al.
patent: 1749829 (2006-03-01), None
Miller et al., “Identification and isolation of a membrane protein necessary for leukotrine production,” Nature 343:278-281 (1990) Abstract only.
PCT/US06/39421 Search Report dated Jan. 18, 2008.

Affiliated with

Also associated with

Rating

5-lipoxygenase-activating protein (FLAP) inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-lipoxygenase-activating protein (FLAP) inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-lipoxygenase-activating protein (FLAP) inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2749768